Underlying diseases | Total | Short-term bedridden group | Middle-term bedridden group | Long-term bedridden group | P |
---|---|---|---|---|---|
n (%)/M ± SD | n = 101 | n = 46 | n = 23 | n = 32 | |
Complicated with underlying diseases | 94 (93.1%) | 42 (91.3%) | 22 (95.7%) | 30 (93.8%) | 0.785 |
Number of underlying diseases | 3.06 ± 1.70 | 2.27 ± 1.47 | 3.48 ± 1.38 | 3.88 ± 1.76 | < 0.001 |
High blood pressure | 68 (67.3%) | 26 (56.5%) | 19 (82.6%) | 23 (71.9%) | 0.075 |
Cerebrovascular disease | 57 (56.4%) | 14 (30.4%) | 21 (91.3%) | 22 (68.8%) | < 0.001 |
Anemia | 51 (50.5%) | 23 (50%) | 12 (52.2%) | 16 (50%) | 0.983 |
Coronary heart disease | 40 (39.6%) | 9 (19.6%) | 13 (56.5%) | 18 (56.3%) | < 0.001 |
Diabetes | 25 (24.8%) | 9 (19.6%) | 9 (39.1%) | 7 (21.9%) | 0.168 |
Alzheimer’s disease | 24 (24.0%) | 7 (15.6%) | 4 (17.4%) | 13 (40.6%) | 0.035 |
Arrhythmia | 21 (20.8%) | 1 (2.2%) | 7 (30.4%) | 13 (40.6%) | < 0.001 |
Tumor history | 16 (15.8%) | 6 (13%) | 3 (13%) | 7 (21.9%) | 0.533 |
Respiratory diseases | 14 (13.9%) | 10 (21.7%) | 1 (4.3%) | 3 (9.4%) | 0.130 |
Smoking history | 14 (13.9%) | 1 (2.2%) | 8 (34.8%) | 5 (15.6%) | < 0.001 |
History of fragile fracture | 20 (19.8%) | 8 (17.4%) | 2 (8.7%) | 10 (31.3%) | 0.101 |
Chronic respiratory failure | 5 (5.0%) | 4 (8.7%) | 0 (0) | 1 (3.1%) | 0.370 |
Chronic cardiac insufficiency | 4 (4.0%) | 1 (2.2%) | 0 (0) | 3 (9.4%) | 0.199 |
Parkinson’s syndrome | 4 (4%) | 2 (4.3%) | 0 (0) | 2 (6.3%) | 0.685 |
Long-term oral hormones | 3 (3%) | 3 (6.5%) | 0 (0) | 0 (0) | 0.318 |
Indwelling urinary catheters | 36 (35.6%) | 11 (23.9%) | 10 (43.5%) | 15 (46.9%) | < 0.001 |
Long-term nasal feeding | 35 (34.7%) | 7 (15.2%) | 9 (39.1%) | 19 (59.4%) | 0.077 |